RJFSA
SAGE icon

Raymond James Financial Services Advisors’s Sage Therapeutics SAGE Stock Holding History

Raymond James Financial Services Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,061
Closed -$293K – 2788
2019
Q4 		$293K Sell
4,061
-112
-3% -$13.8K ﹤0.01% 2333
2019
Q3 		$585K Sell
4,173
-18
-0.4% -$3.01K ﹤0.01% 1805
2019
Q2 		$767K Sell
4,191
-433
-9% -$73.9K ﹤0.01% 1654
2019
Q1 		$735K Sell
4,624
-325
-7% -$47.1K ﹤0.01% 1642
2018
Q4 		$474K Sell
4,949
-306
-6% -$35K ﹤0.01% 1707
2018
Q3 		$742K Buy
5,255
+481
+10% +$74.2K ﹤0.01% 1657
2018
Q2 		$747K Buy
4,774
+2,308
+94% +$362K ﹤0.01% 1607
2018
Q1 		$397K Buy
2,466
+1,025
+71% +$174K ﹤0.01% 1857
2017
Q4 		$237K Sell
1,441
-6,594
-82% -$639K ﹤0.01% 2153
2017
Q3 		$501K Sell
8,035
-647
-7% -$50.8K ﹤0.01% 1715
2017
Q2 		$691K Buy
8,682
+2,525
+41% +$183K ﹤0.01% 1492
2017
Q1 		$438K Sell
6,157
-1,405
-19% -$82.3K ﹤0.01% 1662
2016
Q4 		$386K Buy
+7,562
New +$356K ﹤0.01% 1672

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Raymond James Financial Services Advisors's SAGE Position: Q1 2020 in Review

Raymond James Financial Services Advisors sold out of Sage Therapeutics (SAGE) in Q1 2020, closing a stake of 4,061 shares — an estimated $293K sold.

Raymond James Financial Services Advisors first reported a position in SAGE in Q4 2016 and held it in 13 quarters. The position peaked at $767K in Q2 2019. 230 funds tracked by Wall St. Rank hold SAGE as of Q1 2020.

  • Raymond James Financial Services Advisors reported no remaining Sage Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 4,061 Sage Therapeutics shares in Q1 2020, an estimated $293K.
  • Raymond James Financial Services Advisors first reported a position in Sage Therapeutics in Q4 2016 and held it in 13 quarters.
  • Raymond James Financial Services Advisors's Sage Therapeutics position peaked at $767K in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2020, filed 21 Apr 2020.